ZONAGEN INC
10-Q, EX-11, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ZONAGEN INC, 10-Q, 2000-11-14
Next: ZONAGEN INC, 10-Q, EX-27, 2000-11-14



<PAGE>   1
                                                                    EXHIBIT 11.1


              STATEMENT REGARDING COMPUTATION OF NET LOSS PER SHARE

THREE MONTHS ENDED SEPTEMBER 30, 2000

<TABLE>
<CAPTION>
                   Net Loss        Weighted Average Shares Outstanding          Loss per Share
                   --------        -----------------------------------          --------------
<S>               <C>              <C>                                          <C>
Basic             $1,293,890        divided by     11,316,069       =               $0.11
Diluted           $1,293,890        divided by     11,316,069       =               $0.11
</TABLE>

NINE MONTHS ENDED SEPTEMBER 30, 2000

<TABLE>
<CAPTION>
                   Net Loss        Weighted Average Shares Outstanding          Loss per Share
                   --------        -----------------------------------          --------------
<S>               <C>              <C>                                          <C>
Basic             $4,234,189        divided by      11,297,850       =              $0.37
Diluted           $4,234,189        divided by      11,297,850       =              $0.37
</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission